Qiagen stock after-hours at EUR 39.86: plus 6.26 percent versus prior close
Published on 10/02/2026 at 19:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Qiagen stock was at EUR 39.86 after-hours at 7:45 p.m. CEST on October 2, 2026. The price was up plus 6.26 percent versus the prior close of EUR 37.51 at Lang & Schwarz.
Qiagen shares rise in after-hours trading
The Lang & Schwarz price was recorded on October 2, 2026. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Qiagen stock.
FDA clearance expands QIAstat-Dx portfolio
In a September 28, 2026 release, QIAGEN said U.S. laboratories had access to its complete QIAstat-Dx bloodstream-infection portfolio following FDA clearance of the QIAstat-Dx BCID GN Plus AMR Panel. The panel identifies 13 gram-negative bacterial targets and 18 antimicrobial-resistance markers in about one hour. Together with a complementary panel for gram-positive bacteria and fungi, the two panels cover 33 pathogen targets and 28 resistance markers.
Automation portfolio expanded
QIAGEN also announced the launch of QIAmini on September 24, 2026. According to the company’s release, the compact system processes up to eight samples per run and reduced hands-on time by more than 80 percent across evaluated workflows.
